IDERA PHARMACEUTICALS INC (IDRA) Stock Income Statement
USA - NASDAQ:IDRA - US45168K4058 - Common Stock
0.425 USD
-0.12 (-21.57%)
0.42 USD
-0.01 (-1.18%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.45M | 660.00K | |||
| Operating Expenses | 17.36M | 26.35M | 36.69M | 47.34M | 57.26M | |||
| Research and Development | 8.06M | 16.38M | 24.77M | 34.85M | 41.84M | |||
| Selling, General, and Administrative Expenses | 9.34M | 9.98M | 11.92M | 12.48M | 15.42M | |||
| Operating Income | -17.36M | -26.35M | -36.69M | -45.89M | -56.60M | |||
| Interest Income/Expense | 253.00K | 6.96M | 130.00K | 520.00K | 1.08M | |||
| Other Income/Expense | 0.00 | 118.80M | -76.11M | -10.96M | N/A | |||
| Non Recurring Items | N/A | -1.32M | 0.00 | -180.00K | -4.36M | |||
| Income Before Taxes | -22.74M | 98.09M | -112.66M | -56.52M | -59.88M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -17.85M | 96.94M | -112.66M | -84.56M | -59.88M | |||
| EBITDA | -17.34M | -26.33M | -36.63M | -45.77M | -56.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.34 | 1.93 | -3.33 | -2.96 | -2.25 | |||
| Non GAAP EPS | N/A | 2.34 | -3.85 | -2.94 | -2.27 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -5831.72% | -9072.73% | |||
| Operating Profit Margin | N/A | N/A | N/A | -3164.83% | -8575.76% | |||
All data in USD